| Autor: |
Burnett RW, D'Orazio P, Fogh-Andersen N, Kuwa K, Külpmann WR, Larsson L, Lewnstam A, Maas AH, Mager G, Spichiger-Keller U |
| Jazyk: |
angličtina |
| Zdroj: |
Clinica chimica acta; international journal of clinical chemistry [Clin Chim Acta] 2001 May; Vol. 307 (1-2), pp. 205-9. |
| DOI: |
10.1016/s0009-8981(01)00431-4 |
| Abstrakt: |
In human beings, glucose is distributed like water between erythrocytes and plasma. The molality of glucose (amount of glucose per unit water mass) is the same throughout the sample. Different water concentrations in calibrator, plasma, and erythrocyte fluid can explain some differences that are dependent on sample type, methods requiring sample dilution, and direct reading biosensors detecting molality. Different devices for the measurement of glucose detect and report fundamentally different analytical quantities. The differences exceed the maximum allowable error of glucose determinations for diagnosing and monitoring diabetes mellitus, and they complicate the treatment. The goal of the International Federation of Clinical Chemistry, Scientific Division, Working Group on Selective Electrodes (IFCC-SD WGSE) is to reach a global consensus on reporting results. The document recommends harmonizing to the concentration of glucose in plasma (with the unit mmol/l), irrespective of sample type or technology. A constant factor of 1.11 will convert measured concentration in whole blood to the equivalent concentration in plasma. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect